Treatment patterns and cost of nonmelanoma skin cancer management

Dermatologic Surgery

Volumn 32, Issue 10, 2006, Pages 1266-1271

  John Chen, G ^a   Yelverton, Christopher B ^b   Polisetty, Sudhir S ^b   Housman, Tamara S ^b   Williford, Phillip M ^b   Teuschler, Hoa V ^b   Feldman, Steven R ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMBULATORY SURGERY; ARTICLE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OPERATING ROOM; OUTPATIENT; PATIENT CARE; PHYSICIAN; PRIORITY JOURNAL; SKIN CANCER; TREATMENT INDICATION; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MEDICARE; PREVALENCE; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; UNITED STATES;

EID: 33749984418     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2006.32288.x     Document Type: Article

References (38)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994;30:774-8.
2. Giles GG, Marks R, Foley P. Incidence of non-melanocytic skin cancer treated in Australia. Br Med J (Clin Res Ed) 1988;296:13-7.
3. Cancer Facts & Figures 2000 [monograph on the Internet]. Atlanta: American Cancer Society; 2001. Available from: http://www.cancer.org/downloads/ STT/F&F00.pdf
4. Freedberg KA, Geller AC, Miller DR, et al. Screening for malignant melanoma: a cost-effective analysis. J Am Acad Dermatol 1999;41:738-45.
5. Helfand M, Mahon SM, Eden KB, et al. Screening for skin cancer. Am J Prev Med 2001;20:47-58.
6. Skidmore RA Jr, Flowers FP. Nonmelanoma skin cancer. Med Clin North Am 1998;82:1309-23 vi.
7. Gloster HM Jr, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22:217-26.
8. Strom SS. Epidemiology of basal and squamous cell carcinoma of the skin. In: Weber RS, Miller MJ, Goepfert G, editors. Basal and squamous cell skin cancers of the head and neck. Baltimore: Williams & Wilkins, 1996:p. 1-7.
9. Green A. Changing patterns in incidence of non-melanoma skin cancer. Epithelial Cell Biol 1992;1:47-51.
10. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA 1989;262:2097-100.
11. National Cancer Institute. SEER Program. Cancer Facts and Figures-1994. NIH Publication No. 93-2789. Bethesda: US Department of Health & Human Services, Public Health Service, National Institutes of Health; 1993.
12. Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;44:7-26.
13. Weinstock MA. Epidemiologic investigation of nonmelanoma skin cancer mortality: the Rhode Island Follow-Back Study. J Invest Dermatol 1994;102:6S-9S.
14. Weinstock MA, Bogaars HA, Ashley M, et al. Nonmelanoma skin cancer mortality: a population-based study. Arch Dermatol 1991;127:1194-7.
15. Weinstock MA. Nonmelanoma skin cancer mortality in the United States, 1969 through 1988. Arch Dermatol 1993;129:1286-90.
16. Kibarian MA, Hruza GJ. Nonmelanoma skin cancer: risks, treatment options, and tips on prevention. Postgrad Med 1995;98:39-8, 55.
17. Fleischer AB Jr, Feldman SR, White RE, et al. Procedures for skin diseases performed by physicians in 1993 and 1994: analysis of data from the National Ambulatory Medical Care Survey. J Am Acad Dermatol 1997;37:719-24.
18. Smith ES, Feldman SR, Fleischer AB Jr, Leshin B, McMichael A. Characteristics of office-based visits for skin cancer: dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions. Dermatol Surg 1998;24:981-5.
19. Chen G, Fleischer A, Smith ED, et al. Cost of nonmelanoma skin cancer treatment in the United States. Dermatol Surg 2001;27:1035-8.
20. Fleischer AB, Feldman SR, Barlow JO, et al. The specialty of the treating physician affects the likelihood of tumor-free resection margins for basal cell carcinoma: results from a multi-institutional retrospective study. J Am Acad Dermatol 2001;44:224-9.
21. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003;48:425-9.
22. Adler GS. A profile of the Medicare Current Beneficiary Survey. Health Care Financ Rev 1994;15:153-63.
23. Vega-Memije E, De Larios NM, Waxtein LM, Dominguez-Soto L. Cytodiagnosis of cutaneous basal and squamous cell carcinoma. Int J Dermatol 2000;39:116-20.
24. Russell EB, Carrington PR, Smoller BR. Basal cell carcinoma: a comparison of shave biopsy versus punch biopsy techniques in subtype diagnosis. J Am Acad Dermatol 1999;41:69-71.
25. Derrick EK, Smith R, Melcher DH, et al. The use of cytology in the diagnosis of basal cell carcinoma. Br J Dermatol 1994;130:561-3.
26. Presser SE, Taylor JR. Clinical diagnostic accuracy of basal cell carcinoma. J Am Acad Dermatol 1987;16:988-90.
27. Nixon RI, Dorevich AP, Marks R. Squamous cell carcinoma of the skin. accuracy of clinical diagnosis and outcome of follow-up in Australia. Med J Aust 1986;144:235-9.
28. International Classification of Diseases. 9th revision; Clinical Modification. Salt Lake City: Medicode Publications; 1999.
29. Current Procedural Terminology: CPT 2000. Chicago: American Medical Association, 1999.
30. Burton RC, Howe C, Adamson L, et al. General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen 1998;5:156-61.
31. Hornbrook MC, Hurtado AV, Johnson RE. Health care episodes: definition, measurement and use. Med Care Rev 1985;42:163-218.
32. Lapetina EM, Armstrong EM. Preventing errors in the outpatient setting: a tale of three states. Health Aff 2002;Jul/Aug:26-39.
33. Mezei G, Chung F. Return hospital visits and hospital readmissions after ambulatory surgery. Ann Surg 1999;230:721-7.
34. Ray S. Result of 310 consecutive patients undergoing laparoscopic Nissen fund-oplication as hospital outpatients or at a free-standing surgery center. Surg Endosc 2003;17:378-80.
35. Warner MA, Shields SE, Chute CG. Major morbidity and mortality within 1 month of ambulatory surgery and anesthesia. JAMA 1993;270:1437-41.
36. Morello DC, Colon GA, Fredricks S, et al. Patient safety in accredited office surgical facilities. Plast Reconstr Surg 1997;99:1496-500.
37. Vila H Jr, Soto R, Cantor AB, Mackey D. Comparative outcomes analysis of procedures performed in physician offices and ambulatory surgery centers. Arch Surg 2003;138:991-5.
38. Venkat A, Coldiron B, Balkrishnan R, et al. Lower adverse event and mortality rates in physician offices compared with ambulatory surgery centers: a reappraisal of Florida adverse event data. Dermatol Surg 2004;30:14444-1453.